# A Phase 3 Comparative Study of TAP-144-SR(6M) in Prostate Cancer Patients Previously Treated With Hormonal Therapy

> **NCT01546623** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 160 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** TAP-144-SR(6M)
- **DRUG:** TAP-144-SR(3M)

## Key facts

- **NCT ID:** NCT01546623
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2015-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01546623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01546623, "A Phase 3 Comparative Study of TAP-144-SR(6M) in Prostate Cancer Patients Previously Treated With Hormonal Therapy". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT01546623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*